Avera Cancer Sequencing and Analytics Protocol (ASAP)
NCT05142033
Adnexal Diseases, Breast Cancer
Marshall, Minnesota, United States
View Trial DetailsNCT Number: NCT01499394
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients.
The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Interested in participating?
Request Info18 year and older
All sexes
Observational
University of South Alabama, Mobile, Alabama, United States
The Caris Biorepository is an effort toward defining the future of medicine incorporating the discoveries of the genomic era by providing physicians, researchers and scientists access to quality human specimens and data aimed at improving human health and fighting disease. This will be accomplished through acquiring and sharing valuable biospecimen information and clinical outcomes in a collaborative, secure environment. The Caris Biorepository will bridge the gap and correlate human specimens with clinical and specimen data valuable to multiple and varying entities interested in advancing science with precision medicine by targeting disease treatments.
The objective of this project is to develop and implement a state-of-the-science Biorepository that ensures molecular integrity and clinical relevance of human biospecimens used in research and clinical medicine. The Caris Biorepository will also provide vital biospecimens and data to internal researchers and external research collaborators such as government, academia and industry collaborators for the use of drug development discoveries, clinically relevant research trials, publications and posters, and the implementation of future healthcare policies. This project may also impact characterization of trends in practice patterns and their relation to patient outcomes as well as the economic implications of differing evaluation, treatment and management paradigms.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 35 years
Retention of biospecimen samples with DNA
Time frame: 35 years
Research for the purposes of cancer laboratory diagnostic tests.
Time frame: 35 years
DNA and RNA microarray
Time frame: 35 years
Immunohistochemistry
Time frame: 35 years
Gene and protein expression, proteomics and matabolomics
Time frame: 35 years
Mutation analysis
Time frame: 35 years
Experiemental lab testing for development of new diagnostic technology
Time frame: 35 years
Microvesicle discovery, characterization and validation.
Contact information is provided by the study sponsor or research team.
Caris Science, Inc.
Industry
The Caris Biorepository Research Protocol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05142033
Adnexal Diseases, Breast Cancer
Marshall, Minnesota, United States
View Trial DetailsNCT06656728
Cancer, Early Detection of Cancer
Tel Aviv, Israel
View Trial DetailsNCT05227534
Cancer, Circulating Cell-free DNA
Chengdu, Sichuan, China
View Trial DetailsNCT05155605
Cancer, Early Detection of Cancer
Auburn, California, United States
View Trial Details